AIMS-2-Trials researchers at key events in Europe (Nice, 13-15 September 2019)
Consortium members including Ghent University, University of Groningen, and Uppsala University participated throughout the Autism Europe Congress 2019 on 13th – 15th September, delivering keynotes, moderating sessions and as part of the scientific committee.
James Cusack (Autistica) chaired a keynote session on empowerment of autistic people in an inclusive society. Simon Baron-Cohen (University of Cambridge) presented a keynote session summarising research on sex differences in autism and introduced the AIMS-2-TRIALS ACCESS-EU study on understanding access to services across the EU. Sven Bolte (Karolinska Institute, Sweden) presented ‘From Diagnosis to Functioning and Quality of Life with Autism’. More details on https://www.aims-2-trials.eu/2019/11/13/aims-2-trials-researchers-at-key-events-in-europe/